Muir-Torre syndrome: A rare but important disorder

Cutis

Volumn 82, Issue 4, 2008, Pages 252-256

  Hare, Holly H ^a   Mahendraker, Neetu ^b   Sarwate, Sandhya ^b,c   Tangella, Krishnarao ^b,c  

^a University of Missouri   (United States)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^c Christie Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CASE REPORT; FEMALE; HUMAN; MIDDLE AGED; MUIR TORRE SYNDROME;

FEMALE; HUMANS; MIDDLE AGED; MUIR-TORRE SYNDROME;

EID: 56449096436     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Muir EG, Bell AJ, Barlow KA. Multiple primary carcinomata of the colon, duodenum, and larynx associated with keratoacanthomata of the face. Br J Surg. 1967;54:191-195.
2. Torre D. Multiple sebaceous tumors. Arch Dermatol. 1968;98:549-551.
3. Schwartz RA, Torre DP. The Muir-Torre syndrome: a 25-year retrospect. J Am Acad Dermatol. 1995;33:90-104.
4. Cohen PR, Kohn SR, Kurzrock R. Association of sebaceous gland tumors and internal malignancy: the Muir-Torre syndrome. Am J Med. 1991;90:606-613.
5. Cohen PR, Kohn SR, Davis DA, et al. Muir-Torre syndrome. Dermatol Clin. 1995;13:79-89.
6. Curry ML, Eng W, Lund K, et al. Muir-Torre syndrome: role of the dermatopathologist in diagnosis. Am J Dermatopathol. 2004;26:217-221.
7. Paraf F, Sasseville D, Watters A, et al. Clinicopathological relevance of the association between gastrointestinal and sebaceous neoplasms: the Muir-Torre syndrome. Hum Pathol. 1995;26:422-427.
8. Misago N, Yutaka N. Sebaceous neoplasms in Muir-Torre syndrome. Am J Dermatopathol. 2000;22:155-161.
9. Propeck PA, Warner T, Scanlan K. Sebaceous carcinoma of the breast in a patient with Muir-Torre syndrome. AJR Am J Roentgenol. 2000;174:541-542.
10. Johnson P, Heckler E Muir-Torre syndrome. Ann Plast Surg. 1998;40:676-677.
11. Lynch H, Leibowitz R, Smyrk T, et al. Colorectal cancer and the Muir-Torre syndrome in a Gypsy family: a review. Am J Gastroenterol. 1999;95:575-580.
12. Pettey AA, Walsh JS. Muir-Torre syndrome: a case report and review of the literature. Cutis. 2005;75:149-155.
13. Akhtar S, Oza KK, Khan SA, et al. Muir-Torre syndrome: case report of a patient with concurrent jejunal and ureteral cancer and a review of literature. J Am Acad Dermatol. 1999;41(5,pt 1):681-686.
14. Mencía-Guttiérez E, Gutiérrez-Díaz E, Santos-Briz A, et al. Sebaceous gland carcinoma of the eyelid and palpebral conjunctiva in a patient with Muir-Torre syndrome. Br J Ophthalmol. 2000;84:1325-1326.
15. Rishi K, Font R. Sebaceous gland tumors of the eyelids and conjunctiva in the Muir-Torre syndrome. Ophthal Plast Reconstr Surg. 2004;20:31-36.
16. Rodenas JM, Herranz MT, Tercedor J, et al. Muir-Torre syndrome associated with a family history of hyperlipidemia. J Am Acad Dermatol. 1993;28:285-288.
17. Bakker PM, Tjon A, Joe SS. Multiple sebaceous gland tumours with multiple tumours of internal organs: a new syndrome? Dermatologica. 1971;142:50-57.
18. Rulon DB, Helwig EB. Multiple sebaceous neoplasms of the skin: an association with multiple visceral carcinomas, especially of the colon. Am J Clin Pathol. 1973;60:745-752.
19. Navi D, Wadhera A, Fung MA, et al. Muir-Torre syndrome. Dermatol Online J. 2006;12:4.
20. LeBoit PE, Burg G, Weedon D, Sarasin A, eds. World Health Organisation Classification of Tumours: Pathology & Genetics of Skin Tumours. Lyon, France: IARC Press; 2005.
21. Weedon D. Skin Pathology. 2nd ed. New York, NY: Churchill Livingstone; 2002.
22. Entius MM, Keller JJ, Drillenburg P, et al. Microsatellite instability and expression of hMLH-1 and hMSH-2 in sebaceous gland carcinomas as markers for Muir-Torre syndrome. Clin Cancer Res. 2000;6:1784-1789.
23. Kruse R, Rütten A, Lamberti C, et al. Muir-Torre phenotype has a frequency of DNA mismatch-repair-gene mutations similar to that in hereditary nonpolyposis colorectal cancer families defined by the Amsterdam criteria. Am J Hum Genet. 1998;63:63-70.
24. Mangold E, Pagenstecher C, Leister M, et al. A genotypephenotype correlation in HNPCC: strong predominance of msh2 mutations in 41 patients with Muir-Torre syndrome. J Med Genet. 2004;41:567-572.
25. Mathiak M, Rutten A, Mangold E, et al. Loss of DNA mismatch repair proteins in skin tumors from patients with Muir-Torre syndrome and MSH2 or MLH1 germ-line mutations: establishment of immunohistochemical analysis as a screening test. Am J Surg Pathol. 2002;26:338-343.
26. Singh RS, Grayson W, Redston M, et al. Site and tumor type predicts DNA mismatch repair status in cutaneous sebaceous neoplasia. Am J Surg Pathol. 2008;32: 936-942.
27. Lynch H, Fusaro R. The Muir-Torre syndrome in kindreds with hereditary nonpolyposis colorectal cancer (Lynch syndrome): a classic obligation in preventive medicine. J Am Acad Dermatol. 1999;41:797-799.